Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Sol-Gel To Tackle Gorlin Syndrome In Pact With BridgeBio’s PellePharm

27 Jan 2023

• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Deal Watch 2021 — • Source: Shutterstock

Related Content

Editas Slims Down To Focus On Gene-Editing Sickle Cell Therapy Race

11 Jan 2023

The Best Of J.P. Morgan – Valuations, Deals And The IRA

16 Jan 2023

IRA Implications Will Factor Significantly In Deal Strategy In 2023

16 Jan 2023

Big Antibody Deals Offer Hope Amid Challenging Times For China Biotech

17 Jan 2023

Elicio Uses Reverse Merger With Angion To Go Public At Last

18 Jan 2023

New Deals, Modalities In Sights In Japan After Relatively Quiet 2022

19 Jan 2023

FDA Asks Hyloris For More Data On Maxigesic IV

05 Jul 2022

Sandoz Adds To Anti-Infectives With Astellas Mycamine Deal

24 Jan 2023

Standalone Sandoz And Biocon’s Biosimilars: 2022’s Biggest Deals

18 Jan 2023

Midatech Survival Plan Scuppered By Shareholders

25 Jan 2023

Top 5 Deals Of 2022: The Economic Drag On M&A Continues

25 Jan 2023

Pfizer Takes First Small Step Into Longevity Field With Gero Collaboration

25 Jan 2023

India M&As Overtook PE Activity In 2022, Deal Momentum To Continue In 2023

25 Jan 2023

Amylyx’s Relyvrio Could See Fast Sales Growth, But Also Spark Pricing Debate

30 Sep 2022

US Rights Deal Will Make Proleukin Clinigen's Biggest Product

13 Feb 2019

Deal Watch: Sanofi Teams Up With Biond On Novel Checkpoint Inhibitor

13 Jan 2021

Finance Watch: Insilico Raises $255m To Take AI-Discovered Drugs Into The Clinic

23 Jun 2021

Sun Pharma Will Take Concert’s Alopecia Drug The Rest Of The Way

19 Jan 2023

Janssen Follows AbbVie To Exit From Morphic Deal, But Lead Asset Still Has Chance

23 Jan 2023

Takeda Pays Big For De-Risked HutchMed CRC Drug

23 Jan 2023

Finance Watch: Fundraising Shows Preference For Later-Stage Companies

23 Jan 2023

The Hunt For Big Fish: How KDDF Is Helping Create Korean Deals

25 Jan 2023

How HALO Slip Proved Costly For CinCor In AstraZeneca Talks

24 Jan 2023

Related Companies

Sol-Gel Technologies, Ltd.

BridgeBio Pharma, Inc.

PellePharm, Inc.

Editas Medicine

Shoreline Biosciences, Inc.

Hyloris Pharmaceuticals SA

Salus Therapeutics Inc.

Mabwell (Shanghai) Bioscience Co., Ltd.

Disc Medicine, Inc.

Amylyx Pharmaceuticals, Inc.

Neopharm Co Ltd

Flame Biosciences, Inc.

Boryung Pharmaceutical Co., Ltd.

Bristol Myers Squibb Company

Clinigen Group plc

Iovance Biotherapeutics, Inc.

Novartis AG

Torii Pharmaceutical Co. Ltd.

Amolyt Pharma

XOMA Royalty Corporation

Helsinn Healthcare SA

Immedica Pharma AB

Swixx BioPharma AG

VectorY Therapeutics

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.